Clinical and Experimental Rheumatology's 2026 Journal Metrics Score is 1.2, ranking Q3 in Rheumatology and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 2.39.
Middle 50%: 71–125 days
100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025
Clinical and Experimental Rheumatology accepts papers a median of 94 days after submission, including peer review and revisions. That is faster than 66% of comparable journals with PubMed timing data.
No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
139 of 1,617 works · same type, year & subfield
7 works · same type, year & subfield
Below field-year expectation
of 1,132 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.58, so its typical recent paper runs about 42% below its field benchmark.
8.6% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2016–2025
1,617 OpenAlex works · 2021–2024
OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.
Select a MeSH signal to see how much Clinical and Experimental Rheumatology publishes on it, from PubMed counts for the last five complete years.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Rheumatology | Q3 |
| Pathology and Forensic Medicine | Q3 |
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
Clinical and Experimental Rheumatology's 2026 Journal Metrics Score is 1.2, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
Clinical and Experimental Rheumatology's best quartile is Q3. By OpenAlex subfield: Q3 in Rheumatology; Q3 in Pathology and Forensic Medicine. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Clinical and Experimental Rheumatology will not match this score exactly. Compare journals using one source at a time.
Clinical and Experimental Rheumatology accepts papers a median of 94 days after submission across 100 recent PubMed records with both dates; the middle half took 71–125 days. This includes peer review, editorial handling, and revisions.
PubMed records when a manuscript was received and accepted, not the individual review stages, so peer review time on its own is not available. The full time from submission to acceptance at Clinical and Experimental Rheumatology, which includes peer review and revisions, has a median of 94 days. For the time to a first decision, check the journal's own website.
Clinical and Experimental Rheumatology's median of 94 days from submission to acceptance is faster than 66% of comparable journals with PubMed timing data.
Comparable journals include Archives of Rheumatology, Current Opinion in Rheumatology, Arthritis & Rheumatology, and Advances in Rheumatology. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.